The Fellowship Training Program in Pediatric Hematology-Oncology at Jackson Memorial Hospital in affiliation with the University of Miami-Miller School of Medicine is fully accredited by the Accreditation Council for Graduate Medical Education and is meant to fulfill the ACGME requirements for pediatric hematology and oncology training with an emphasis on clinical and research training in benign (non-malignant) hematology, malignant hematology, pediatric oncology and pediatric bone marrow transplantation.
Upon completion of the training program, fellows will have demonstrated sufficient competence to enter the practice of pediatric hematology-oncology without direct supervision and will be prepared to conduct meaningful clinical, translational, or laboratory-based research.
There will also be offered a one year non-accredited training in bone marrow transplantation for interested individuals for additional training after their fellowship.
ACGME Accredited: Yes
Residents or Fellows per year: One
Duration: Three years
Postgraduate Training Required: Yes
U.S. Citizenship Required: No, we also accept J-1 and H-1B visas.
The candidate should have completed a Residency in General Pediatrics at an ACGME accredited Pediatric Residency Program.
All applicants should register through Electronic Residency Application Service (ERAS) for match in the spring each year.
Applications are reviewed starting December 01 and interviews are scheduled starting January 01 and up to March 30 each year.
Completed application, submitted via ERAS includes:
- Completed application, including photograph
- Curriculum Vitae (CV)
- Personal statement
- Medical school transcript
- USMLE Scores
- Letter of recommendation from the Pediatric Residency Program Director
- Two-Three additional letters of recommendation
- ECFMG certificate (international graduates only)
- Pediatric Residency Completion Certificate (upon entering program)
Clinical experiences for training in this hematology/oncology/BMT program will be comprised of 97% clinical rotations during the first year and 35% clinical exposure during the second year and third year (inpatient rotations, night call and continuity clinic); research exposure will comprise 3% of the trainee’s effort during the first year and 65% of the time during the second and third year.
Although most of the clinical rotations take place during the first year of fellowship training, clinical training in pediatric hematology-oncology occurs throughout all three years. Thus, under the supervision and guidance of the faculty, the fellows will assume graded responsibility as educational experience and procedural skills increase.
- Inpatient (14 months)
- Ward service
- 7 months during the first year
- 3 months during the second year
- 2 months during the third year
- Bone marrow (autologous, allogenic and stem cell) transplantation
- 1 month during the first year
- 1 month during the third year
- Ward service
- Electives (6 weeks during the first year)
- Blood bank (2 weeks)
- Hematopathology (2 weeks)
- Radiation-oncology (2 weeks)
- Research exploration (4 weeks divided in 2-week blocks)
- Outpatient benign hematology (1 month during the first year)
- Continuity Clinic (3 years)
Educational & Other Experience
Continuity clinic is an important aspect of ambulatory exposure and an essential piece of the curriculum. The fellow will be able to provide longitudinal follow-up of a core group of patients in both malignant and non-malignant hematology.
Each Fellow will be assigned to one continuity day which will be constant for the duration of each academic year (July-June) which will comprise a broad spectrum of benign hematology patients including those with sickle cell disease, bone marrow failure, disorders of platelets and those with disorders of hemostasis and thrombosis and general hematology such as anemias as well as oncology patients comprising- leukemias and lymphomas, solid tumor patient- sarcomas, bone tumors, kidney tumors, neuroblastomas, brain tumors etc. At the end of each year, the fellows will switch clinic days to expand their exposures to specific hematology-oncology conditions; those continuity patients, if feasible, will move with the Fellow to his/her new clinic day.
The Fellow will be responsible for planning diagnostic evaluations, researching protocols when applicable, following up on labs/procedures/imaging and discussing with the specific attending. The Fellow should be involved in all the pre-clinic discussions regarding management/evaluations.
There will be formal educational offerings mostly every day of the week during the academic year (August – June). An overview of the core conferences is as follows:
|Outpatient- Case discussions||Core curriculum||Tumor Board (bimonthly)||Board Review,(bimonthly)||Hematopathology Session (Monthly)|
On Tuesday’s morning (8 – 9 am) core curriculum lectures will be presented by the Faculty, fellows (with the supervision of a faculty member) or an invited speaker from outside Divisions. The topics will include core Faculty presentations (reviews of topics, discussion of individual research), outside presentations – palliative care, pain center, radiation oncology, hemophilia physical therapy among others — Fellow-lead topical discussions, and Journal Club. There will also be lectures led by the representatives of the Miami Clinical and Translational Science Institute which are intended to present an approach which will allow the Fellows to critically analyze academic articles and publications.
The bimonthly Tumor Board will occur the first and third Wednesday of each month. Selected cases from either the inpatient or outpatient areas will be presented by the fellows (with the supervision of the Faculty with more expertise on that area). The presentations will include a brief overview of the disease under consideration. The designated faculty discussants – either from Hem-Onc or an outside specialty – will be expected to provide more background into the options for management, as well as their experiences with similar cases. A Site Disease Specific Group Meeting which will be held for a half hour at the end of the Tumor Board on the third Wednesday of the month which will involve the presentation and discussion of new COG and transplant protocols utilizing in-house faculty, other members within the Department of Medicine and visiting faculty.
All Fellows will also be encouraged to attend Grand Rounds/seminars scheduled at Sylvester Comprehensive Cancer Center, and they may choose to attend those that are of interest; this will also provide an avenue for identifying a research/lab mentor.
Approximately 70% of the hematology-oncology fellow’s effort will be focused on research.
All Fellows are expected to create a primary research project – bench or clinical – under the mentorship of one of the Hematology/Oncology Faculty members. In addition, there needs to be a secondary project. A goal for the program is that that ALL Fellows have basic lab/bench exposure during their 3 years.
Fellows are expected to create their primary project, and are responsible for consents, IRB submission, and recruitment, if applicable. Each Fellow is expected to have a manuscript ready for journal submission by graduation. There is also the expectation that either or both the primary and the secondary project will allow the Fellow to prepare abstracts and posters for submission to one of the national meetings. Fellows will be also encouraged and supported by the Program Directors, as well as by Division attendings to identify patients for case reports and poster sessions at national/scholarly meetings.
The First Year Fellow will be expected to have a direction for his/her primary project by month 6 of his first year. He/she should have identified an area of study – ie, sickle cell disease, leukemia, etc —and a potential mentor. With this purpose, the First Year Fellow will have a 4 week “research block” (divided in 2-week blocks) to allow him/her to focus on developing his/her primary and secondary projects. Unscheduled clinical time during the outpatient/elective months are also to be spent focusing on upcoming research plans.
In accordance with the ACGME guidelines, three months after the beginning of the second year of training, the fellow will present his/her research project to the Scholarship Oversight Committee (SOC) for additional vetting and approval. The SOC is comprised of four researchers (2 clinical researchers and 2 physician scientists). One of these four should be from outside the Division to provide greater objectivity to the SOC. This group will provide guidance for the fellows in their progress through a research project.
The fellow will prepare a written individualized research plan and present this to their SOC twice in the second year (early winter and early summer) outlining their progress and plans. It is the responsibility of the SOC and the research mentor to guide the fellow through project development → approval → data generation → data analysis and presentation → manuscript and/or grant submission.
All Fellows will also participate in the Resident Scholarly Activity Program (RSAP); a well-organized program, in where through a series of online and live sessions; Fellows are taught to navigate the academic process, gaining understanding of what is necessary to create, research and institute a research project. All Fellows are expected to produce an extra manuscript appropriate for publication as a consequence of this Program.
- Each fellow will be responsible for carrying the on-call beeper/cellphone one week per month (home-call).
- Fellows will take weekend calls twice a month during the first year and once a month during the second and third years of training.
• Holtz Children’s Hospital
Jackson Memorial Medical Center
• Sylvester Comprehensive Cancer Center
University of Miami-Miller School of Medicine